muramidase has been researched along with Hepatitis--Viral--Human* in 4 studies
1 review(s) available for muramidase and Hepatitis--Viral--Human
Article | Year |
---|---|
[Faecal enzyme diagnostic (author's transl)].
The hitherto existing results of determinations of enzymatic activities in stool are presented in this review. The chymotrypsin activity is diminished in advanced exocrine pancreatic insufficiency. The faecal alpha-amylase activity has up to now no significance in the diagnosis of pancreatic diseases. Up to five amylolytic enzyme activities are detectable. The alkaline phosphatase is mostly of intestinal origin. Up to 4 enzyme bands can be exhibited with the disc electrophoresis in polyacrylamide gel. Lysozyme and N-Acetyl-beta-D-glycosaminidase can also be detected in stool. Topics: Alkaline Phosphatase; Amylases; Animals; Chymotrypsin; Colitis, Ulcerative; Cystic Fibrosis; Enzyme Induction; Feces; Hepatitis, Viral, Human; Hexosaminidases; Humans; Intestinal Mucosa; Malabsorption Syndromes; Muramidase; Pancreatic Diseases; Protozoan Infections; Rats; Trypsin | 1979 |
3 other study(ies) available for muramidase and Hepatitis--Viral--Human
Article | Year |
---|---|
[Effects of lysozyme treatment on immune reactions in viral hepatitis. Preliminary report].
The effect of orally administered Lysozyme (2 g per diem for 6-15 days) on serum immunoglobulins, C3 complement component, its C3A properdine activator and intestinal flora was studied in 45 subjects with acute viral hepatitis. Comparison of the data before and after treatment revealed a significant decrease in IgA, IgM and C3A and an equally significant increase in C3. Coproculture tests revealed important changes in many case in which one or more pathogenetic species (Enterobacter, Proteus, Citrobacter) had completely disappeared. The mechanisms used by Lysozyme in the modulation of immunological responses during viral hepatitis are discussed. These include reduction of the enteric antigen stimulus by inhibiting the growth of bacterial flora, the blocking of anti-complement factors and the modification of antibody response. Topics: Adolescent; Adult; Antibody Formation; Complement C3; Complement C3a; Enterobacter; Feces; Female; Hepatitis, Viral, Human; Humans; Immunoglobulins; Male; Middle Aged; Muramidase | 1983 |
[Clinical significance of serum lysozyme in viral hepatitis].
Topics: Adolescent; Adult; Carrier State; Hepatitis, Viral, Human; Humans; Male; Muramidase | 1977 |
[Condition of nonspecific immunity in children with viral hepatitis].
Topics: Child; Child, Preschool; Complement System Proteins; Hepatitis, Viral, Human; Humans; Infant; Muramidase; Properdin | 1977 |